DRGEM Corporation (KQ:263690) — Market Cap & Net Worth
Market Cap & Net Worth: DRGEM Corporation (263690)
DRGEM Corporation (KQ:263690) has a market capitalization of $39.50 Million (₩58.29 Billion) as of June 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22819 globally and #1498 in its home market, demonstrating a 9.07% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DRGEM Corporation's stock price ₩5350.00 by its total outstanding shares 10895516 (10.90 Million). Review 263690 current and long-term liabilities to assess the company's total debt and financial obligations.
DRGEM Corporation Market Cap History: 2018 to 2026
DRGEM Corporation's market capitalization history from 2018 to 2026. Data shows change from $46.14 Million to $39.50 Million (-1.76% CAGR).
Index Memberships
DRGEM Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$276.99 Billion | 0.01% | #745 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$276.99 Billion | 0.01% | #745 of 1384 |
Weight: DRGEM Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
DRGEM Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DRGEM Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
DRGEM Corporation's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
DRGEM Corporation's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $46.14 Million | $56.63 Billion | $4.65 Billion | 0.00x | 0.01x |
| 2019 | $56.53 Million | $60.09 Billion | $5.47 Billion | 0.00x | 0.01x |
| 2020 | $116.69 Million | $106.60 Billion | $19.99 Billion | 0.00x | 0.01x |
| 2021 | $83.34 Million | $85.75 Billion | $12.55 Billion | 0.00x | 0.01x |
| 2022 | $75.90 Million | $110.17 Billion | $14.39 Billion | 0.00x | 0.01x |
| 2023 | $76.86 Million | $112.92 Billion | $9.19 Billion | 0.00x | 0.01x |
| 2024 | $41.94 Million | $104.01 Billion | $10.15 Billion | 0.00x | 0.00x |
| 2025 | $39.43 Million | $102.75 Billion | $6.78 Billion | 0.00x | 0.01x |
Competitor Companies of 263690 by Market Capitalization
Companies near DRGEM Corporation in the global market cap rankings as of June 18, 2026.
Key companies related to DRGEM Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
DRGEM Corporation Historical Marketcap From 2018 to 2026
Between 2018 and today, DRGEM Corporation's market cap moved from $46.14 Million to $ 39.50 Million, with a yearly change of -1.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩39.50 Million | +0.19% |
| 2025 | ₩39.43 Million | -5.99% |
| 2024 | ₩41.94 Million | -45.44% |
| 2023 | ₩76.86 Million | +1.27% |
| 2022 | ₩75.90 Million | -8.93% |
| 2021 | ₩83.34 Million | -28.58% |
| 2020 | ₩116.69 Million | +106.42% |
| 2019 | ₩56.53 Million | +22.53% |
| 2018 | ₩46.14 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of DRGEM Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.50 Million USD |
| MoneyControl | $39.50 Million USD |
| MarketWatch | $39.50 Million USD |
| marketcap.company | $39.50 Million USD |
| Reuters | $39.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About DRGEM Corporation
DRGEM Corporation manufactures and sells diagnostic radiography systems. It offers high frequency X-ray generators; conventional and digital radiography systems; and ACQUIDR, a digital imaging system. DRGEM Corporation exports its products. The company was founded in 2003 and is headquartered in Gwangmyeong-si, South Korea.